Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH
Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH
USE OUR INTELLIGENCE

Financial Incentives Boost Weight-Loss Programs
PUBLIC HEALTH
December 6, 2022

Financial Incentives Boost Weight-Loss Programs

Paying cash to people with obesity for losing a specific amount of weight or completing…

USE OUR INTELLIGENCE December 6, 2022
Why Synonymous Mutations Are Not Always Silent
RESEARCH
December 6, 2022

Why Synonymous Mutations Are Not Always Silent

New modeling shows how synonymous mutations — those that change the DNA sequence of a…

USE OUR INTELLIGENCE December 6, 2022
Auto Draft
TECHNOLOGY
December 6, 2022

New Mobile Health Technology for Sleep Apnea Care to Address Individual Patient Needs

Sleeping with a Continuous Positive Airway Pressure, or CPAP, machine is the most effective treatment…

USE OUR INTELLIGENCE December 6, 2022
Off-Patent Liver Disease Drug Could Prevent Covid-19 Infection and Protect Against Future Variants
VIRUSES & VACCINES
December 6, 2022

Off-Patent Liver Disease Drug Could Prevent Covid-19 Infection and Protect Against Future Variants

Cambridge scientists have identified an off-patent drug that can be repurposed to prevent COVID-19 –…

USE OUR INTELLIGENCE December 6, 2022
The Future of Replacement Organs Is (Quite Possibly) Here: Robust Human Intestinal Organoids Created in a Lab
RESEARCH
December 6, 2022

The Future of Replacement Organs Is (Quite Possibly) Here: Robust Human Intestinal Organoids Created in a Lab

Growing human body parts in the lab is a common trope of horror movies and…

USE OUR INTELLIGENCE December 6, 2022
University of Missouri Researchers Design New Heart Health Wearable
TECHNOLOGY
December 6, 2022

University of Missouri Researchers Design New Heart Health Wearable

While heart disease is a leading cause of death in the United States, most people…

USE OUR INTELLIGENCE December 6, 2022
Scientists Find Inorganic Food Additives Might Make Babies More Vulnerable to Allergies
RESEARCH
December 6, 2022

Scientists Find Inorganic Food Additives Might Make Babies More Vulnerable to Allergies

Nanotechnologies have revolutionized food technology with changes to food production, manufacture, and processing that are…

USE OUR INTELLIGENCE December 6, 2022
Direct-To-Consumer Online Platforms Expand Access, but Often Fail to Convey Risks of Testosterone Therapy
PUBLIC HEALTH
December 6, 2022

Direct-To-Consumer Online Platforms Expand Access, but Often Fail to Convey Risks of Testosterone Therapy

Demand for testosterone therapy has soared in the United States with more men seeking to…

USE OUR INTELLIGENCE December 6, 2022
Finding the Right AI for You
TECHNOLOGY
December 6, 2022

Finding the Right AI for You

AI is a powerful tool for studying the human genome. But its recent popularity has…

USE OUR INTELLIGENCE December 6, 2022
Forest Resilience Linked with Higher Mortality Risk in Western U.S.
ENVIRONMENT
December 6, 2022

Forest Resilience Linked with Higher Mortality Risk in Western U.S.

A forest’s resilience, or ability to absorb environmental disturbances, has long been thought to be…

USE OUR INTELLIGENCE December 6, 2022
Older Posts Newer Posts
Latest Posts
  • Check for Copycat Bias in Medical AI
    TECHNOLOGY
    Check for Copycat Bias in Medical AI
    USE OUR INTELLIGENCE September 2, 2026
  • Brain Cancer: Immunotherapy First, Surgery Afterwards
    NEUROLOGY & MENTAL HEALTH, PHARMA & CLINICAL TRIALS
    Brain Cancer: Immunotherapy First, Surgery Afterwards
    USE OUR INTELLIGENCE September 2, 2026
  • Your Smartwatch Is Lying to You About How Many Calories You Burned, FIU Study Finds
    TECHNOLOGY
    Your Smartwatch Is Lying to You About How Many Calories You Burned, FIU Study Finds
    USE OUR INTELLIGENCE September 2, 2026
  • FDA Approves Breakthrough Pancreatic Cancer Drug – an Oncologist Explains How Daraxonrasib Nearly Doubles Survival
    PHARMA & CLINICAL TRIALS
    FDA Approves Breakthrough Pancreatic Cancer Drug – an Oncologist Explains How Daraxonrasib Nearly Doubles Survival
    USE OUR INTELLIGENCE September 2, 2026
  • Not All ‘Magic’ Mushrooms Are the Same
    PUBLIC HEALTH
    Not All ‘Magic’ Mushrooms Are the Same
    USE OUR INTELLIGENCE September 2, 2026
Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH

©2026. Global Health News Wire. Use Our Intel. All Rights Reserved. Washington, D.C.

Global Health News Wire
  • HOME
  • GHNW Notes
  • PERMISSIONS AND POLICIES
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH

©2026. Global Health News Wire. Use Our Intel. All Rights Reserved. Washington, D.C.

I would like to receive critical industry news to my inbox.

Our site uses cookies. Learn more about our use of cookies: Cookie Policy

ACCEPT